
Mangalam Drugs & Organics Limited – NSE:MANGALAM.NS
Mangalam Drugs & Organics Limited stock price today
Mangalam Drugs & Organics Limited stock price monthly change
Mangalam Drugs & Organics Limited stock price quarterly change
Mangalam Drugs & Organics Limited stock price yearly change
Mangalam Drugs & Organics Limited key metrics
Market Cap | 1.81B |
Enterprise value | 2.57B |
P/E | 14.9 |
EV/Sales | 0.62 |
EV/EBITDA | 7.22 |
Price/Sales | 0.43 |
Price/Book | 1.15 |
PEG ratio | -0.50 |
EPS | -5.72 |
Revenue | 3.67B |
EBITDA | 174.47M |
Income | -90.71M |
Revenue Q/Q | 8.71% |
Revenue Y/Y | -0.68% |
Profit margin | 3% |
Oper. margin | 5.95% |
Gross margin | 35.82% |
EBIT margin | 5.95% |
EBITDA margin | 4.75% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMangalam Drugs & Organics Limited stock price history
Mangalam Drugs & Organics Limited stock forecast
Mangalam Drugs & Organics Limited financial statements
Jun 2023 | 870.03M | -95.35M | -10.96% |
---|---|---|---|
Sep 2023 | 813.66M | -35.64M | -4.38% |
Dec 2023 | 970.45M | 4.97M | 0.51% |
Mar 2024 | 1.02B | 35.30M | 3.45% |
Jun 2023 | 0 | 0 | |
---|---|---|---|
Sep 2023 | 3806814000 | 2.48B | 65.22% |
Dec 2023 | 0 | 0 | |
Mar 2024 | 3334242000 | 1.97B | 59.27% |
Mar 2023 | 54.99M | 0 | 0 |
---|---|---|---|
Jun 2023 | 68.37M | 0 | 0 |
Sep 2023 | 74.78M | 0 | 0 |
Dec 2023 | 72.57M | 0 | 0 |
Mangalam Drugs & Organics Limited alternative data
Aug 2023 | 479 |
---|---|
Sep 2023 | 479 |
Oct 2023 | 523 |
Nov 2023 | 523 |
Dec 2023 | 523 |
Jan 2024 | 523 |
Feb 2024 | 523 |
Mar 2024 | 523 |
Apr 2024 | 523 |
May 2024 | 523 |
Jun 2024 | 523 |
Jul 2024 | 523 |
Mangalam Drugs & Organics Limited other data
-
What's the price of Mangalam Drugs & Organics Limited stock today?
One share of Mangalam Drugs & Organics Limited stock can currently be purchased for approximately $137.8.
-
When is Mangalam Drugs & Organics Limited's next earnings date?
Unfortunately, Mangalam Drugs & Organics Limited's (MANGALAM.NS) next earnings date is currently unknown.
-
Does Mangalam Drugs & Organics Limited pay dividends?
No, Mangalam Drugs & Organics Limited does not pay dividends.
-
How much money does Mangalam Drugs & Organics Limited make?
Mangalam Drugs & Organics Limited has a market capitalization of 1.81B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 17.89% to 3.67B US dollars.
-
What is Mangalam Drugs & Organics Limited's stock symbol?
Mangalam Drugs & Organics Limited is traded on the NSE under the ticker symbol "MANGALAM.NS".
-
What is Mangalam Drugs & Organics Limited's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Mangalam Drugs & Organics Limited?
Shares of Mangalam Drugs & Organics Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Mangalam Drugs & Organics Limited have?
As Jul 2024, Mangalam Drugs & Organics Limited employs 523 workers.
-
When Mangalam Drugs & Organics Limited went public?
Mangalam Drugs & Organics Limited is publicly traded company for more then 20 years since IPO on 23 May 2005.
-
What is Mangalam Drugs & Organics Limited's official website?
The official website for Mangalam Drugs & Organics Limited is mangalamdrugs.com.
-
How can i contact Mangalam Drugs & Organics Limited?
Mangalam Drugs & Organics Limited can be reached via phone at +91 22 2261 6200.
Mangalam Drugs & Organics Limited company profile:

Mangalam Drugs & Organics Limited
mangalamdrugs.comNSE
432
Drug Manufacturers - Specialty & Generic
Healthcare
Mangalam Drugs & Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. It offers a range of active pharmaceutical ingredients, intermediates, and specialty chemicals, as well as impurities for use in anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral applications. The company was incorporated in 1972 and is based in Mumbai, India.
Mumbai, 400001
:
ISIN: INE584F01014
: